Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus Erythematosus

INTRODUCTION: Despite current standard of care (SoC), there is an unmet need for the treatment of active systemic lupus erythematosus (SLE). The study assessed the cost-effectiveness of Acthar(®) Gel (repository corticotropin injection) versus SoC treatment in patients with active, moderate-to-sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Bindra, Jas, Chopra, Ishveen, Hayes, Kyle, Niewoehner, John, Panaccio, Mary, Wan, George J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859852/
https://www.ncbi.nlm.nih.gov/pubmed/36266383
http://dx.doi.org/10.1007/s12325-022-02332-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859852/
https://www.ncbi.nlm.nih.gov/pubmed/36266383
http://dx.doi.org/10.1007/s12325-022-02332-w

Ejemplares similares